An observational study in Organ Donation After Circulatory Death, sponsored by University of British Columbia. Not yet recruiting at 13 sites in Canada. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-11-03.
Sponsored by University of British Columbia · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 43 studies in Death with a site in Canada — 6 open to participants now, 9 under way, 1 of them phase 3. Death · Canada.
Among the 43 studies in Death with a site in Canada, this one is the 17th largest by planned enrollment of the 19 observational ones that give a count, is the only one that started in 2027, is one of 19 observational ones, and was the 43rd registered.
457 studies on the registry are indexed under Death; 85 are open to participants now.
Browse Death studies →6 of the 43 studies in Death with a site in Canada are open now. Recruiting first, the newest first:
Royal Victoria Hospital, Canada · Sites in Canada
Ages 80+
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Sites in Canada
Ages 18+
University of Pennsylvania · Sites in Canada, United States
Ages 0 days–9 wk
Nova Scotia Health Authority · Sites in Canada
Ages 18+
Ottawa Hospital Research Institute · Sites in Canada
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 58 Death studies recruiting now, 43 (74%) set no upper age limit and 8 (14%) stop at 75 or younger; 11 take children under 18; 14 take healthy volunteers.
This study: 19 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
43 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 4 · Phase 3 4
First in 2001; this study’s year is marked. 1 started in 2027.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 102 is below the median of 400 across 236 observational studies indexed under Death.
Median enrollment 258 across the 24 interventional studies, 417 across the 19 observational. Of the 29 that completed or were terminated, 3 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 43 have an industry lead sponsor. The 10 most frequent:
University of British Columbia is the lead sponsor of 1,342 studies on the registry; 262 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.
University of British Columbia has 1 study filed under Death — fewer than ten, so there is no comparison to draw.
4 of the studies in Death with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04171830Ottawa Hospital Research InstituteClinical Surveillance Tool to Screen for Unmet Palliative Needs Among Patients in the Final Year of Life | 2026-12 |
| NCT06002113Royal Victoria Hospital, CanadaEliciting Informed Goals of Care in Elderly Patients | 2026-12-31 |
| NCT05306327London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sNeurologic Physiology After Removal of Therapy (NeuPaRT) | 2027-03 |
| NCT05446272University of PennsylvaniaThe Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial | 2027-03-31 |
Add all 4 to your calendar (.ics) → With an account.
Among the 43 studies in Death with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to develop a new tool that uses information collected before life-sustaining treatments are withdrawn to better predict whether a patient will die within the time needed for organ donation to be possible. The tool created should help improve planning for organ donation and provide families and healthcare teams with more accurate information.
ICU
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
To develop a clinically applicable model to predict dying duration in a cohort of patient eligible for donation after circulatory death
Specifically, we aim at assessing the predictive ability of blood-based brain biomarkers, optic nerve sheet diameter as measured by head computed tomography (CT) scans as a surrogate of intracranial pressure and autonomic dysfunction as reflected by abnormal heart rate variability (HRV) to predict the dying duration.
Time frame: The models will be built to predict death within 30, 60 and 120 minutes
Comparison of the brain-to-heart model to existing models
Our secondary aim will be to compare the created models with available models (e.g., DCD-N, UNOS, Wisconsin) and to physician gestalt
Time frame: The models will be compared for death within 30, 60 and 120 minutes
Plan to share: No — Data will be avaiable to be shared on demand. However, statistical analysis and prediction modeling computer code will be made publicly available on GitHub.
No publications or documents are linked to this record.
Start is estimated for Jan 2027; primary completion for Dec 2030, 47 months later.
Of 85 non-industry observational studies under Death, half reached primary completion within 69 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 245. This study's planned 47 months is below that.
Counting every sponsor, half of 88 studies reached it within 69 months; a quarter within 23 and three quarters within 245.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of British Columbia →